Charles River Laboratories International, Inc. (CRL)

[H2R]

Two Divestitures: RMS Japan and CDMO Sweden

WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 12, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced that it has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions.

https://ir.criver.com/news-releases/news-release-details/charles-river-laboratories-announces-two-divestitures